Key Segmentation
By Offering
-
Products
-
Services
By Technology
-
CRISPR-Cas9
-
Base Editing
-
Prime Editing
-
CRISPR-Cas12
-
Others
By Application
-
Biomedical and Therapeutics
-
Agriculture and Environmental
-
Industrial and Others
By End User
-
Pharma and Biotech Companies
-
Academic and Research Institutes
-
Contract Research Organizations
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the market include Thermo Fisher Scientific, Merck KGaA, GenScript Biotech, Danaher, Agilent Technologies, and CRISPR Therapeutics, among others.
Key opportunities include in vivo editing for common diseases and deregulation of gene-edited crops in agriculture.
Clinical success and large patient populations are the major growth factors, as approved therapies raise demand for tools, services, and manufacturing assays.
The Products segment dominated the market in 2025 with approximately 70.12% share, as every experiment and program needs enzymes, guide RNAs, plasmids, libraries, and kits.
North America dominated the market in 2025 with approximately 44.04% share, supported by research funding, a deep venture ecosystem, and the presence of the largest tool suppliers and therapeutic developers.